Skip to content
Governance Register

← US public companies

R&R Acquisition VI, INC

SEC CIK 1368514 · ADMA · last insider filing 2026-05-28

Directors (from insider filings)

NameCapacity as filedFilings
Grossman Jerrold B Director filed 2012 - 2026
Grossman Adam S Director · President,CEO, and Interim CFO filed 2012 - 2026
Guiheen Lawrence P. Director filed 2012 - 2026
Elms Steve Director filed 2012 - 2026
Finger Alison Cecily Director filed 2023 - 2026
Kwon Young Director filed 2021 - 2026
Salas Eduardo Rene Director filed 2025 - 2026
Fong Bryant Director filed 2012 - 2024
Demski Martha J Director filed 2020 - 2023
Goldstein DOV A MD Director filed 2012 - 2020
Richman Eric I Director filed 2012 - 2020
Biotest Pharmaceuticals Corp Director filed 2017 - 2018
Biotest AG Director filed 2017 - 2018
Ehmer Bernhard Director filed 2017 - 2017
Burrill Capital Fund IV, L.P. Director filed 2012 - 2013
Burrill Steven Director filed 2012 - 2012
Wetherell David S Director filed 2012 - 2012
Kling Arnold P Director · President filed 2006 - 2012

Officers (from insider filings)

NameTitle as filedFilings
Kestenberg-Messina Kaitlin M. COO and SVP, Compliance filed 2024 - 2026
Kohler Terry CFO and Treasurer filed 2026 - 2026
Tade Brad L. CFO and Treasurer filed 2024 - 2026
Lenz Brian VP, CFO filed 2012 - 2024
Mond James EVP, CSO and CMO filed 2012 - 2021
Warshaw Kirk M CFO, Secretary filed 2006 - 2012

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.